Zribi, A., Al Riyami, K., Al Zahibi, H. S. and Burney, I. A. (2024) “Managing the Adverse Events Associated with Pembrolizumab and Lenvatinib Therapy in Endometrial Cancer”, Sultan Qaboos University Medical Journal, 24(2), pp. 293–297. doi: 10.18295/squmj.9.2023.057.